aztreonam has been researched along with Sensitivity and Specificity in 10 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
Sensitivity and Specificity: Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aztreonam was combined with ciprofloxacin, gatifloxacin, levofloxacin, cefepime, ceftazidime and imipenem at clinically relevant concentrations." | 1.32 | Contemporary in vitro synergy rates for aztreonam combined with newer fluoroquinolones and beta-lactams tested against gram-negative bacilli. ( Huynh, HK; Jones, RN; Sader, HS, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ansari, M | 1 |
| Munir, T | 1 |
| Saad, N | 1 |
| Rhomberg, PR | 1 |
| Jones, RN | 2 |
| Sader, HS | 1 |
| Huynh, HK | 1 |
| Cuzzolin, L | 1 |
| Lolli, P | 1 |
| Piccinelli, D | 1 |
| Dagradi, V | 1 |
| Benoni, G | 1 |
| Mole, R | 1 |
| Trollip, A | 1 |
| Abrahams, C | 1 |
| Bosman, M | 1 |
| Albert, H | 1 |
| Honderlick, P | 1 |
| Gravisse, J | 1 |
| Dardelle, D | 1 |
| Cahen, P | 1 |
| Martínez-Beltrán, J | 1 |
| Cantón, R | 1 |
| Liñares, J | 1 |
| García de Lomas, J | 1 |
| Gimeno, C | 1 |
| Tubau, F | 1 |
| Baquero, F | 1 |
| Vercauteren, E | 1 |
| Descheemaeker, P | 1 |
| Ieven, M | 1 |
| Sanders, CC | 1 |
| Goossens, H | 1 |
| Zimmer, BL | 1 |
| Brattebo, J | 1 |
| Bryant, M | 1 |
| Capo, A | 1 |
| Chipman, A | 1 |
| Miller, R | 1 |
| Wehr, C | 1 |
| Van Pelt, L | 1 |
| Shehabi, AA | 1 |
| Mahafzah, A | 1 |
| Baadran, I | 1 |
| Qadar, FA | 1 |
| Dajani, N | 1 |
10 other studies available for aztreonam and Sensitivity and Specificity
| Article | Year |
|---|---|
Phenotypic Identification, Frequency Distribution and Antibiogram of Carbapenemase Producing Enterobacteriaceae in Clinical Isolates.
Topics: Amoxicillin; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; beta-Lactams; Ca | 2018 |
Antimicrobial spectrum of activity for meropenem and nine broad spectrum antimicrobials: report from the MYSTIC Program (2002) in North America.
Topics: Anti-Bacterial Agents; Aztreonam; Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacteria | 2003 |
Contemporary in vitro synergy rates for aztreonam combined with newer fluoroquinolones and beta-lactams tested against gram-negative bacilli.
Topics: Aztreonam; beta-Lactams; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Ente | 2003 |
Aztreonam concentrations in colonic tissue in patients undergoing abdominal surgery.
Topics: Anti-Bacterial Agents; Aztreonam; Colon; Digestive System Surgical Procedures; Humans; Infusions, In | 1989 |
Improved contamination control for a rapid phage-based rifampicin resistance test for Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Aztreonam; Humans; Microbial Sensitivity Tests; Mycobacteriophages; Mycobacte | 2007 |
[Is aztreonam could become "a challenger" for treatment of Gram negative infections? May be an answer from microbiological data: in vitro study including 36,485 strains of enterobacteria and Pseudomonas].
Topics: Anti-Bacterial Agents; Aztreonam; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Ha | 2007 |
Multicentre comparative study on the antibacterial activity of FK-037, a new parenteral cephalosporin.
Topics: Aztreonam; Cefepime; Cefotaxime; Cefpirome; Ceftazidime; Ceftizoxime; Cephalosporins; Gram-Negative | 1995 |
Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital.
Topics: Aztreonam; beta-Lactamases; Cefepime; Ceftazidime; Ceftriaxone; Cephalosporins; DNA, Bacterial; Elec | 1997 |
Correlation of aztreonam susceptibility results obtained with the MicroScan system to reference tests.
Topics: Aztreonam; Bacteriological Techniques; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; M | 1997 |
High incidence of Klebsiella pneumoniae clinical isolates to extended-spectrum B-lactam drugs in intensive care units.
Topics: Aztreonam; beta-Lactam Resistance; Cefotaxime; Ceftazidime; Ceftriaxone; Cross Infection; Gram-Negat | 2000 |